Biotech vs. Shorts Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech vs. Shorts

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (119)	8/9/1999 8:18:00 PM
From: scaram(o)uche	Read Replies (1) of 427

regarding the increased volume in GLIA, significantly increased demand but the declining price....... yahoo.marketguide.com Data for the top three institutional holders is in for the second quarter (thanks, Spyros). As others have indicated, both Shaker and Lord Abbett increased their positions, while Wisconsin's position was unchanged. While increased volume was observed for the last 2/3 of June, the really big volume didn't get rolling until July. It's therefore sort of difficult to fully evaluate this data. However, it leans, IMO, to the same place that other observations have led..... manipulation. Quick question.... the process of undeclared shorting has been discussed in the thread. Is it legal?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next